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A B S T R A C T
Purpose
Alcohol intake is associated with increased risk of breast cancer. In contrast, the relation between
alcohol consumption and breast cancer survival is less clear.
Patients and Methods
We assessed pre- and postdiagnostic alcohol intake in a cohort of 22,890 women with incident
invasive breast cancer who were residents of Wisconsin, Massachusetts, or New Hampshire and
diagnosed from 198 to 200 at ages 20 to 79 years. All women reported on prediagnostic intake;
a subsample of 4,881 reported on postdiagnostic intake.
Results
During a median follow-up of 11.3 years from diagnosis, 7,780 deaths occurred, including 3,484
resulting from breast cancer. Hazard ratios (HR) and 95% CIs were estimated. Based on a
quadratic analysis, moderate alcohol consumption before diagnosis was modestly associated with
disease-specific survival (compared with nondrinkers, HR  0.93 [95% CI, 0.85 to 1.02], 0.85 [95%
CI, 0.75 to 0.95], 0.88 [95% CI, 0.75 to 1.02], and 0.89 [95% CI, 0.77 to 1.04] for two or more, three
to six, seven to nine, and  10 drinks/wk, respectively). Alcohol consumption after diagnosis was
not associated with disease-specific survival (compared with nondrinkers, HR  0.88 [95% CI,
0.61 to 1.27], 0.80 [95% CI, 0.49 to 1.32], 1.01 [95% CI, 0.55 to 1.87], and 0.83 [95% CI, 0.45 to
1.54] for two or more, three to six, seven to nine, and  10 drinks/wk, respectively). Results did
not vary by beverage type. Women consuming moderate levels of alcohol, either before or after
diagnosis, experienced better cardiovascular and overall survival than nondrinkers.
Conclusion
Overall alcohol consumption before diagnosis was not associated with disease-specific survival, but we
found a suggestion favoring moderate consumption. There was no evidence for an association with
postdiagnosis alcohol intake and breast cancer survival. This study, however, does provide support for a
benefit of limited alcohol intake for cardiovascular and overall survival in women with breast cancer.
J Clin Oncol 31:1939-1946. © 2013 by American Society of Clinical Oncology
INTRODUCTION
Women with breast cancer may be concerned that
their lifestyle choices before diagnosis will affect
their prognosis and may wonder whether modi-
fying these behaviors might improve survival.1-4
One readily modified factor is alcohol intake. Ev-
idence is now incontrovertible that even moder-
ate alcohol consumption increases risk of breast
cancer5-11; for each drink increase in average
daily alcohol consumption, the relative risk of
breast cancer increases by 7%.8 There is, however,
mixed information on whether prediagnostic al-
cohol consumption is related to breast cancer
survival12-31 and limited literature on the associa-
tion between postdiagnostic alcohol intake
and survival.17,27
Most studies have observed no relation be-
tween prediagnostic alcohol intake and breast
cancer–specific or overall survival12-14,17-27; how-
ever, some have found poorer disease-specific
survival,15-17 and others have found better overall
survival among drinkers.28-31 Studies of overall
survival among women with breast cancer include
deaths from other cancers and chronic diseases,
including cardiovascular disease, the latter being
consistent in its inverse association with alco-
hol intake.32-34
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The health impact of alcohol consumption after a breast cancer
diagnosis is salient for the 3,000,000 breast cancer survivors in the
United States today.35,36 To more fully evaluate this association, we
analyzed data from a well-characterized cohort of 22,890 women with
incident invasive breast cancer who reported on alcohol history and
other factors before diagnosis.37 We also examined a sub-cohort of
these women who completed surveys on alcohol consumption and
other behaviors after diagnosis.38-41
PATIENTS AND METHODS
Collaborative Breast Cancer Study: Prediagnosis
Alcohol Consumption
The Collaborative Breast Cancer Study (CBCS) began in 1988 as a mul-
tisite population-based case-control study of risk factors for breast cancer in
New Hampshire, Massachusetts, and Wisconsin.37,42 A total of 23,344 women
with incident breast cancer were enrolled during five successive study phases.
Age eligibility varied by phase: from ages 20 to 74 years (1988 to 1991), to ages
50 to 79 years (1992 to 1995), and, more recently, ages 20 to 69 years at
diagnosis (1997 to 2008). Approximately 80% of eligible women invited to join
the study agreed to participate. For these analyses, we excluded 433 women
(2%) with missing information on prediagnostic alcohol consumption, and 21
women (0.1%) with unknown vital status, leaving 22,890 eligible women.
Collaborative Women’s Longevity Study: Postdiagnosis
Alcohol Consumption
After the completion of the CBCS, patients were invited to participate in
a survivorship cohort, termed the Collaborative Women’s Longevity Study
(CWLS). From 1998 to 2001, we mailed a follow-up questionnaire to 14,621
women known to be alive to assess how exposures may have changed after
diagnosis. In total, 5,791 women (40%) returned the follow-up questionnaire.
We excluded 34 women (0.6%) who had been diagnosed with metastatic
disease at baseline, 617 women (11%) who reported a breast cancer recur-
rence, 155 women (3%) who reported that breast cancer treatment signifi-
cantly interfered with diet, and 104 women (2%) missing data from the
postdiagnosis alcohol questions. After these exclusions, 4,881 women were
included in postdiagnosis analyses. All study activities were approved by
the respective study sites’ institutional review boards.
Ascertainment of Alcohol Use and Other Risk Factors
At study enrollment, all women completed a structured baseline tele-
phone interview that included information on lifetime alcohol consumption
up to diagnosis, including separate questions on the amount and frequency of
beer, wine, and spirits intake. Typical serving sizes were defined as a 12 oz.
can/bottle of beer, a 5 oz. glass of wine, or a 1.5 oz. serving of spirits.43
The questionnaire also elicited information on other breast cancer risk
factors, including reproductive and menstrual history, physical activity,
height, weight, use of oral contraceptives and postmenopausal hormones, and
personal and family history of cancer. Selected clinical information was ob-
tained from state cancer registries, including date and stage at diagnosis, and
histology.44 The postdiagnosis questionnaire was administered a median of 5.7
years (25th to 75th percentile: 2.7 to 8.8 years) after diagnosis and was similar
to the baseline questionnaire.
Identification of Deaths
Vital status was ascertained through December 31, 2009, using the Na-
tional Death Index (NDI).45,46 Cause of death was assigned according to the
International Classification of Diseases (ICD).47,48 We conducted separate
analyses considering deaths attributable to breast cancer (ICD-9: 174 to 174.9;
ICD-10: C50.0 to C50.9), cardiovascular disease (ICD-9: 390 to 398.9 and 401
to 448.9; ICD-10: I00 to I99), and any cause.
Statistical Analysis
Survival time was calculated from the date of diagnosis to death or the
end of follow-up (December 31, 2009). We assessed the frequency and type of
alcohol consumption in the year before diagnosis and in the year before the
postdiagnostic questionnaire. We considered the dose response for alcohol
consumption in categories of drinks per week and, separately, by including
linear and quadratic terms for drinks per week. Proportional hazards regres-
sion was used to estimate adjusted hazard ratios (HR) and 95% CIs for
associations with survival across categories of alcohol consumption.49 All
regression models stratified the baseline hazard on study phase, age at diagno-
sis, state of residence, and stage at diagnosis. For analyses involving prediag-
nostic alcohol consumption, several correlates measured during the baseline
questionnaire were identified a priori as adjustment variables and categorized
as in Table 1: first-degree family history of breast cancer, age at first birth,
menopausal status, postmenopausal hormone use, recent body mass index
(BMI, in kilograms per square meter), smoking status, education, and mam-
mography screening 1 to 5 years before diagnosis. Models also included the
duration of the interval between diagnosis and completion of baseline inter-
view. Women were classified as postmenopausal if they (1) experienced a
natural menopause, (2) had a hysterectomy with bilateral oophorectomy, (3)
were aged  55 without bilateral oophorectomy, or (4) were using hormone
therapy without bilateral oophorectomy.
For analyses involving postdiagnostic alcohol consumption, follow-up
time was calculated from the date of return of the CWLS questionnaire until
the date of death or December 31, 2009. Models included the same variables as
in prediagnostic analyses. In addition to prediagnostic BMI, we adjusted for
the change between pre- and postdiagnosis BMI (five categories of loss/gain)
and for prediagnostic alcohol consumption.
We performed several secondary analyses. For both pre- and postdiag-
nostic alcohol intake, we considered separate models according to breast
cancer histology (ductal or lobular) and menopausal status at diagnosis. To
evaluate the possibility that severity of illness affected alcohol intake, we con-
ducted analyses excluding women who died within 2 years of completing the
postdiagnosis survey (n  95), those who did not report a mammogram or
physician breast exam any time after their diagnosis (n  153), and those who
reported being in poor health (n  44). We also calculated HRs for postdiag-
nostic intake that were not adjusted for prediagnostic consumption and not
stratified by stage. Finally, we considered associations according to changes in
consumption before and after diagnosis. All P values are two-sided, with
P  .05 considered statistically significant without consideration of multiple




The median duration of follow-up after diagnosis was 11.3 years.
During this time, 7,780 deaths occurred, including 3,484 resulting
from breast cancer, 1,531 resulting from cardiovascular disease, and
2,765 resulting from other causes. Of the 22,890 women who com-
pleted the baseline questionnaire, 4,396 (19%) reported never drink-
ing, 11,497 (50%) consumed one to two drinks/wk, 3,583 (16%)
consumed three to six drinks/wk, 1,647(7%) consumed seven to nine
drinks/wk, and 1,767(8%) consumed  10 drinks/wk. Compared
with those who abstained from alcohol before diagnosis, drinkers were
younger, of lower BMI, higher education, and were more likely to have
smoked and used hormones (Table 1).
Associations between increasing prediagnostic alcohol con-
sumption and disease-specific survival were not linear. Relative to
nondrinkers, improved survival was observed for moderate prediag-
nostic consumption (three to six drinks/wk), and no association was
observed for heavy consumption ( 10 drinks/wk; Table 2). These
estimates were similar to minimally adjusted HRs (not shown) indi-
cating minimal confounding by measured covariates. To further ex-
plore the dose-response pattern for alcohol consumption and
mortality, we included quadratic terms to account for a U-shaped
Newcomb et al
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Table 1. Characteristics at Breast Cancer Diagnosis According to Prediagnostic Alcohol Consumption
Characteristic
Prediagnostic Alcohol Consumption (drinks/wk) (N  22,890)
0 (n  4,396)
 2
(n  11,497) 3-6 (n  3,583) 7-9 (n  1,647)
 10
(n  1,767)
No. % No. % No. % No. % No. %
Age, years
 50 695 16 3,039 26 990 28 323 20 357 20
50-59 1,114 25 3,473 30 1,104 31 491 30 556 31
60-69 1,712 39 3,666 32 1,154 32 614 37 637 36
70-79 875 20 1,319 11 335 9 219 13 217 12
State of residence
MA 1,075 24 2,578 22 782 22 454 28 450 25
NH 435 10 737 6 215 6 182 11 172 10
WI 2,886 66 8,182 71 2,586 72 1011 61 1,145 65
First-degree family history of breast cancer
No 3,373 77 9,019 78 2,800 78 1,266 77 1,317 78
Yes 909 21 2,278 20 729 20 350 21 360 20
Unknown 114 3 200 2 54 2 31 2 36 2
Age at first birth, years
 20 745 17 1,544 13 445 12 144 9 227 13
20-24 1,718 39 4,607 40 1,406 39 676 41 655 37
25-29 881 20 2,678 23 836 23 383 23 397 22
 30 404 9 1,234 12 380 11 166 10 164 9
Nulliparous 620 14 1,389 12 505 14 267 16 317 18
Unknown 28 1 45 0 11 0 11 1 7 0
Menopausal status
Premenopausal 787 18 3,295 29 1,078 30 365 22 429 24
Postmenopausal 3,419 78 7,554 66 2,297 64 1,198 78 1258 71
Unknown 190 4 648 6 208 6 84 5 80 5
Postmenopausal hormone use†
Never 2,099 61 3,976 53 1,136 49 620 52 693 55
Former 319 9 802 11 268 12 121 10 117 9
Current‡ 591 17 1,928 26 656 29 333 28 311 25
Unknown 410 12 848 11 237 10 124 10 137 11
Body mass index, kg/m2
 18.5 77 2 177 2 56 2 41 2 48 3
18.5-24.9 1,646 37 5,128 45 2,026 57 975 59 977 55
25.0-29.9 1,376 31 3,628 32 1,022 29 448 27 520 29
 30 1,205 27 2,458 21 452 13 174 11 204 12
Unknown 92 2 106 1 27 1 9 1 18 1
Smoking status
Never 2,559 58 6,308 55 1,499 42 551 33 422 24
Former 1,120 25 3,215 28 1,307 36 678 41 680 38
Current‡ 706 16 1,945 17 770 21 413 25 658 37
Unknown 11 0 29 0 7 0 5 0 7 0
Education
Less than high school diploma 795 18 1,171 10 274 8 114 7 170 10
High school diploma 1,939 44 4,903 43 1,401 39 645 39 749 42
Some college 923 21 2,837 25 905 25 432 26 417 24
College degree 716 16 2,552 22 996 28 453 28 421 24
Unknown 23 1 34 0 7 0 3 0 10 1
Mammography
Never 966 22 2,216 19 669 19 278 17 322 19
Ever 2,777 63 7781 68 2,468 69 1,137 69 1,145 65
Unknown 653 15 1,500 13 446 12 232 14 290 16
Stage of disease
Localized 2,621 60 7,061 61 2,217 62 1,054 64 1,099 62
Regional 1,290 29 3,422 30 1,035 29 425 26 484 27
Distant 126 3 212 2 60 2 32 2 36 2
Unknown 359 8 802 7 271 8 136 8 148 8
Alcohol consumption as reported on baseline questionnaire.
†Premenopausal women are not included.
‡Current as of year before diagnosis.
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relation. When we did so, with 28 drinks/wk as the maximum allow-
able value, this quadratic term was statistically significantly associated
with breast cancer-specific survival (P  .03). In general, our results
were similar according to breast cancer histology (Appendix Table A1,
online only).
HRs for the association between alcohol consumption and car-
diovascular disease survival also suggested a U-shaped pattern with
increasing alcohol consumption. A quadratic term for alcohol intake
was associated with cardiovascular disease (P  .01) and all-cause
mortality (P  .001). Trends for disease-specific and overall survival
did not vary much by beverage type. Consumption of wine was asso-
ciated with increased cardiovascular disease survival, whereas beer and
spirit intake appeared to be associated with decreased cardiovascular
disease survival, but these estimates are based on limited sample sizes
and should be interpreted with caution.
Postdiagnostic Alcohol Consumption
In total, 1,140 women (23%) reported never drinking alcohol
after their breast cancer diagnosis, 2,232 (46%) consumed one to two
drinks/wk, 790 (1%) consumed three to six drinks/wk, 305 (%) con-
sumed seven to nine drinks/wk, and 414 (9%) consumed  10
drinks/wk (Table 3). Compared with those who abstained from alco-
hol after diagnosis, drinkers were younger at diagnosis, more edu-
cated, and more likely to have had a mammogram before study
enrollment (Appendix Table A2, online only). As was the case for
prediagnostic alcohol consumption, heavy drinkers were more likely
to smoke. Postdiagnostic drinkers were also more likely to have gained
weight after diagnosis compared with postdiagnostic nondrinkers.
Disease-specific survival was similar in women who drank alco-
hol after diagnosis as compared with nondrinkers (Table 3). There was
no association for a nonlinear term for weekly alcohol intake and
breast cancer mortality (P  .78). No beverage-specific associa-
tions were observed. Trends in postdiagnostic consumption by histol-
ogy were not considered because very few women with lobular disease
were included in the survival cohort.
Women who consumed higher levels of alcohol after diagno-
sis were less likely than nondrinkers to die from cardiovascular
disease. There was a similar association between increasing alcohol
consumption and more favorable overall survival. The quadratic
terms for cardiovascular disease-specific (P  .07) and all-cause
mortality (P  .04) suggested that the relation with alcohol intake
was nonlinear.
There remained no association between postdiagnostic alcohol
consumption in models that did not adjust for prediagnostic alcohol
intake and stage at diagnosis (data not shown). Results were essentially
unchanged after excluding women who died within 2 years of com-
pleting the survey, did not report having a mammogram or physician
breast exam after their diagnosis, or reported they were in poor health
at the time of the questionnaire.
Change in Alcohol Consumption Before Versus
After Diagnosis
Among women who reported both pre- and postdiagnostic alco-
hol consumption, the average weekly alcohol intake was not substan-
tially different before and after diagnosis (mean drinks/wk: 3.4,
standard deviation [SD] 5.6, prediagnostic; mean drinks/wk 3.2, SD





Breast Cancer Cardiovascular Disease Any Cause
No. %
No. of
Deaths HR 95% CI
No. of
Deaths HR 95% CI
No. of
Deaths HR 95% CI
Total
0 4,396 19 726 1 Reference 454 1 Reference 1,851 1 Reference
1-2 11,497 50 1,769 0.93 0.85 to 1.02 622 0.70 0.61 to 0.79 3,609 0.84 0.80 to 0.90
3-6 3,583 16 487 0.85 0.75 to 0.95 201 0.75 0.63 to 0.90 1,052 0.80 0.74 to 0.86
7-9 1,647 7 228 0.88 0.75 to 1.02 107 0.73 0.58 to 0.91 559 0.85 0.77 to 0.93
 10 1,767 8 274 0.89 0.77 to 1.04 147 0.98 0.80 to 1.20 709 0.96 0.88 to 1.05
Wine
0 8,914 39 1,474 1 Reference 816 1 Reference 3,655 1 Reference
1-2 11,469 50 1,692 0.98 0.91 to 1.06 607 0.77 0.68 to 0.86 3,466 0.88 0.84 to 0.93
3-6 1,521 7 176 0.85 0.72 to 1.01 55 0.65 0.49 to 0.86 348 0.75 0.67 to 0.84
 7 986 4 142 1.11 0.93 to 1.34 53 0.81 0.61 to 1.08 311 0.97 0.85 to 1.09
Beer
0 13,065 57 2,076 1 Reference 1,003 1 Reference 4,900 1 Reference
1-2 7,811 34 1,092 0.94 0.87 to 1.02 378 0.98 0.86 to 1.12 2,150 0.92 0.87 to 0.97
3-6 1,137 5 163 0.90 0.76 to 1.06 82 1.30 1.02 to 1.65 363 0.99 0.89 to 1.11
 7 877 4 153 0.96 0.81 to 1.14 68 1.35 1.04 to 1.75 367 1.13 1.01 to 1.26
Spirits
0 8,702 38 1,358 1 Reference 668 1 Reference 3,156 1 Reference
1-2 11,583 51 1,740 0.92 0.85 to 1.00 629 0.87 0.77 to 0.99 3,578 0.91 0.87 to 0.96
3-6 1,364 6 207 0.91 0.78 to 1.06 94 0.81 0.64 to 1.02 478 0.88 0.80 to 0.97
 7 1,241 5 179 0.86 0.73 to 1.02 140 1.24 1.02 to 1.52 568 1.05 0.95 to 1.15
NOTE. HR adjusted for age at diagnosis, stage of disease at diagnosis, state of residence at diagnosis, study phase, family history of breast cancer, age at first birth,
menopausal status, hormone therapy use, body mass index, smoking status, education, and mammography.
Abbreviation: HR, hazard ratio.
Newcomb et al
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5.8, postdiagnostic). At the extremes, 19% of prediagnostic regular
(three or more drinks/wk) drinkers became nondrinkers after diagno-
sis, whereas 20% of prediagnostic nondrinkers reported regular (three
or more drinks/wk) alcohol consumption after diagnosis. Compared
with women who never consumed alcohol (before or after diagnosis),
women who reported drinking more frequently after their breast
cancer diagnosis were less likely to die from cardiovascular disease,
although there was no association with breast cancer–specific survival
(Table 4).
DISCUSSION
In this large population-based cohort of women with breast cancer, we
found there was no linear association between prediagnostic alcohol
consumption and disease-specific survival, but did find an inverse
association for moderate levels of intake using a quadratic model. We
evaluated whether postdiagnostic alcohol consumption was associ-
ated with survival in a subgroup of this population, independent of





Breast Cancer Cardiovascular Disease Any Cause
No. %
No. of
Deaths HR 95% CI
No. of
Deaths HR 95% CI
No. of
Deaths HR 95% CI
Total
0 1,140 23 69 1 Reference 97 1 Reference 326 1 Reference
1-2 2,232 46 122 0.88 0.61 to 1.27 125 1.00 0.72 to 1.40 467 0.89 0.75 to 1.06
3-6 790 16 39 0.80 0.49 to 1.32 28 0.61 0.37 to 1.03 141 0.77 0.60 to 0.98
7-9 305 6 21 1.01 0.55 to 1.87 11 0.50 0.24 to 1.03 57 0.63 0.45 to 0.88
 10 414 9 25 0.83 0.45 to 1.54 15 0.47 0.24 to 0.91 78 0.64 0.47 to 0.88
Wine
0 1,614 33 100 1 Reference 125 1 Reference 452 1 Reference
1-2 2,451 50 128 1.00 0.70 to 1.42 118 1.07 0.77 to 1.49 483 0.90 0.76 to 1.07
3-6 534 11 27 1.00 0.58 to 1.72 23 1.22 0.67 to 2.20 84 0.76 0.57 to 1.03
 7 282 6 21 1.45 0.77 to 2.73 10 0.81 0.36 to 1.82 50 0.73 0.51 to 1.05
Beer
0 2,830 58 157 1 Reference 195 1 Reference 696 1 Reference
1-2 1,731 36 102 1.26 0.88 to 1.79 74 0.85 0.58 to 1.24 322 1.02 0.85 to 1.23
3-6 215 4 10 1.04 0.49 to 2.22 5 0.68 0.25 to 1.82 32 1.04 0.69 to 1.57
 7 105 2 7 0.94 0.37 to 2.39 2 0.44 0.10 to 2.06 19 0.91 0.53 to 1.57
Spirits
0 2,406 49 146 1 Reference 168 1 Reference 604 1 Reference
1-2 1,826 37 94 0.74 0.53 to 1.03 78 0.78 0.54 to 1.11 327 0.84 0.70 to 1.00
3-6 394 8 20 0.78 0.45 to 1.36 17 0.65 0.35 to 1.21 79 0.86 0.65 to 1.14
 7 255 5 16 0.83 0.43 to 1.62 13 0.51 0.25 to 1.05 59 0.69 0.49 to 0.98
NOTE. HR adjusted for prediagnostic alcohol consumption, age at diagnosis, stage of disease at diagnosis, state of residence at diagnosis, study phase, family
history of breast cancer, age at first birth, menopausal status, hormone therapy use, body mass index, weight change, smoking status, education, and
mammography.
Abbreviation: HR, hazard ratio.
Table 4. Association Between the Change in Alcohol Consumption Before and After Breast Cancer Diagnosis and Death From Breast Cancer, Cardiovascular
Disease, or Any Cause
Change in Alcohol Consumption
Before and After Diagnosis
At Risk
Cause of Death
Breast Cancer Cardiovascular Disease Any Cause
No. %
No. of
Deaths HR 95% CI
No. of
Deaths HR 95% CI
No. of
Deaths HR 95% CI
Total
Never drinker 631 13 31 1 Reference 58 1 Reference 167 1 Reference
 1 drink/wk change 2,096 43 110 0.96 0.63 to 1.46 101 0.64 0.45 to 0.90 418 0.86 0.71 to 1.03
 1 drink/wk decrease 1,241 25 82 1.33 0.87 to 2.05 95 0.87 0.61 to 1.23 336 1.03 0.85 to 1.25
 1 drink/wk increase 913 18 53 1.13 0.70 to 1.80 22 0.39 0.22 to 0.66 148 0.76 0.60 to 0.97
HR per 1 drink/wk change 0.99 0.97 to 1.01 0.96 0.93 to 0.98 0.98 0.97 to 0.99
NOTE. HR adjusted for age at diagnosis, stage of disease at diagnosis, state of residence at diagnosis, study phase, family history of breast cancer, age at first birth,
menopausal status, hormone therapy use, body mass index, weight change, smoking status, education, and mammography.
Abbreviation: HR, hazard ratio.
Zero drinks/week reported on both the prediagnostic and postdiagnostic questionnaire.
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prediagnostic consumption, and found no relation with disease-
specific survival. We also observed that cardiovascular disease sur-
vival and overall survival were improved in women who consumed
moderate levels of alcohol prediagnostically or postdiagnostically,
consistent with prior literature.32,34,50,51 Furthermore, women who
increased their level of alcohol consumption after breast cancer
diagnosis had better survival from cardiovascular disease and
other causes.
Population-based estimates suggest that approximately 65% of
US women consume alcohol.52 Although women may alter their hab-
its after breast cancer diagnosis,53 our results do not support a mean-
ingful effect of changing consumption patterns on breast cancer
survival. Alcohol consumption is believed to influence breast cancer
risk through increases in endogenous estrogens in both pre- and
postmenopausal women.54-56 Limiting estrogen exposure is impor-
tant in controlling breast cancer progression,57 given evidence that
oophorectomy in premenopausal women,58 antiestrogens,59 and aro-
matase inhibitors60 are effective treatments for breast cancer. Reduc-
tions in alcohol intake might, therefore, be plausibly expected to
improve breast cancer survival through similar mechanisms. Such
parallel relationships with incidence and survival, though, have not
always been observed for breast cancer. For example, some expo-
sures known to increase risk of disease, such as hormone therapy or
late age at first birth, do not appear to be positively associated with
mortality in women with breast cancer.18,61-64 If alcohol use is an
important promoting factor, then terminating alcohol use shortly
after diagnosis might result in tumors that would be particularly
responsive to treatment. We did not, however, observe differences
in breast cancer–specific survival in women who continued alcohol
intake postdiagnosis.
There is limited evidence relating postdiagnostic alcohol intake
to clinical outcomes in women with breast cancer. Kwan et al17 ob-
served that disease-specific mortality (n  154 deaths) was increased
in women consuming  6 versus 0 g/d at 2 years postdiagnosis (HR,
1.51; 95% CI, 1.00 to 2.29). Li et al65 reported on a population-based
case-control study of contralateral breast cancer where a statistically
significant doubling of risk of second primary breast cancer was ob-
served in women consuming seven or more drinks per week. Unlike
our study, this design may also reflect the positive effect of alcohol on
breast cancer incidence.5-11 In contrast to Li et al,65 the Women’s
Healthy Eating and Living study found the occurrence of new breast
cancer events (n  518) in breast cancer survivors did not differ
according to baseline alcohol consumption ( 10 g/month v  10
g/month) after a mean follow-up of 7.3 years.27
Cardiovascular disease is increasingly recognized as an important
contributor to mortality among breast cancer survivors.66-68
Deaths owing to cardiovascular causes may be related to the car-
diotoxic and metabolic effects of some breast cancer treatments.69
Our findings suggest that alcohol consumption, before and after
breast cancer diagnosis, is associated with a reduced risk of death
from cardiovascular disease. These results are reassuringly concor-
dant with the previously described role for moderate levels of
alcohol consumption in improved cardiovascular survival, regard-
less of breast cancer status.32,34,50,51
Strengths of this study include its large sample size, long follow-
up, and detailed information on both pre- and postdiagnosis alcohol
intake. We used standardized and reliable instruments for exposures,
including alcohol consumption.70-75 Our measurement of prediag-
nostic alcohol intake was based on recalled alcohol consumption
habits from approximately 2 years before interview. We believe this
retrospective interval yielded valid results, as our previous findings on
alcohol and breast cancer risk in this study population76 were consis-
tent with the results from prospective cohort studies.5,8 We did not
observe major changes in alcohol drinking habits after breast cancer
diagnosis. Reassuringly, in another recent study of alcohol and breast
cancer mortality, 92% of the subset of women with postdiagnosis
alcohol intake reported the same level or adjacent category of intake as
those that reported before diagnosis.14 Our confidence in these study
results is enhanced by the incorporation of information on risk factors
for breast cancer mortality, the minimal confounding by measured
covariates, and the fact that our survival cohort reflects the spectrum
of breast cancer as it occurs in the population.
Some limitations should be considered when interpreting our
results. Hormone receptor status of tumors was not available.
Estrogen receptor–positive tumors are the most common pheno-
type of breast cancer and may be associated with alcohol consump-
tion.22,77,78 However, our inability to control for receptor positivity
is unlikely to lead to an overestimation of the association between
alcohol use and survival. That is, if alcohol use is related to survival
only among those with hormone receptor–positive tumors, the
heterogeneity of tumor types in our sample probably leads to
conservatively biased estimates for alcohol consumption and
survival. Because hormone receptor positivity increases with
increasing age at diagnosis,79 and our sample was primarily post-
menopausal, we suspect that most women’s tumors would have
been hormone receptor positive. We did not have information on
breast cancer recurrence or the occurrence of second primaries,
such as ovarian cancers, which may be associated with alcohol
consumption,80 to support analyses of other end points.
Mammography is particularly important when considering sur-
vival. In our population, alcohol users were slightly more likely to have
ever had a mammogram (68% of drinkers v 63% of nondrinkers).
Because screening history was self-reported by each woman, residual
confounding is possible. It is also conceivable that breast density con-
founded the association between alcohol consumption and breast
cancer survival. Breast density is generally, but not always, positively
associated with markers of poorer prognosis,81-83 and women who
drink are more likely to have greater breast density than those who do
not.84 Additionally, it remains unclear whether the effects of alcohol
on breast cancer development and progression depend on other di-
etary factors, such as folate status,85 which were not available for
our analyses.
One practical concern of our postdiagnosis data is that our results
may only be applicable to women who survive several years after
diagnosis. Not all women with prediagnostic information were partic-
ipants in our evaluation of postdiagnostic alcohol consumption. In
general, women who participated in our postdiagnostic study were
similar to nonresponders with respect to age, stage at diagnosis, repro-
ductive history, and prediagnostic alcohol consumption, although
there were differences in prediagnosis BMI and smoking status.38 We
previously found positive associations of increased alcohol intake with
greater risk of developing breast cancer in our case-control analysis,
consistent with previous prospective and retrospective studies,40,76
indicating that losses owing to death or other causes at the time of
initial enrollment did not distort our evaluation.5-11 In a sensitivity
Newcomb et al
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analysis, we compared the results for prediagnostic alcohol consump-
tion with the more limited CWLS and the total cohort in Table 2.
Overall, the HRs were reassuringly similar (data not shown). Our
observation of better overall survival for alcohol users compared with
nonusers further demonstrates that any losses over follow-up may not
introduce substantial bias. Finally, it is important to note that the
reported level of consumption from a single follow-up questionnaire
may not be fully representative of alcohol use across the entire postdi-
agnosis period.
In summary, this research suggests a U-shaped association be-
tween alcohol intake before breast cancer diagnosis and modestly
better breast cancer survival. We did not observe this relationship with
postdiagnostic alcohol consumption. This study also provides addi-
tional support for a beneficial role for moderate alcohol intake with
respect to cardiovascular-specific and overall survival in women with
breast cancer.
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Appendix
Table A1. Association Between Prediagnostic Alcohol Consumption and Death From Breast Cancer, Cardiovascular Disease, or Any Cause
Prediagnostic Alcohol Consumption
(drinks/wk)







Deaths HR 95% CI No. %
No. of
Deaths HR 95% CI
Total
0 3,500 19 593 1 Reference 392 19 71 1 Reference
1-2 9,100 50 1,443 0.94 0.85 to 1.04 986 49 173 0.93 0.67 to 1.28
3-6 2,856 16 407 0.86 0.75 to 0.98 319 16 50 0.97 0.62 to 1.51
7-9 1,286 7 179 0.86 0.72 to 1.02 147 7 28 1.23 0.74 to 2.05
 10 1,385 8 216 0.86 0.73 to 1.02 170 8 27 0.90 0.53 to 1.52
Wine
0 7,079 39 1,197 1 Reference 800 38 150 1 Reference
1-2 6,104 50 1,386 1.00 0.92 to 1.10 977 49 166 1.00 0.75 to 1.34
3-6 877 5 145 0.89 0.74 to 1.07 141 7 16 0.79 0.44 to 1.43
 7 700 4 110 1.16 0.94 to 1.42 96 5 17 1.34 0.73 to 2.48
Beer
0 10,376 57 1,704 1 Reference 1,132 56 203 1 Reference
1-2 6,164 34 885 0.93 0.85 to 1.02 707 35 110 0.96 0.71 to 1.29
3-6 887 5 125 0.82 0.68 to 0.99 96 5 23 2.74 1.60 to 4.71
 7 700 4 124 0.92 0.76 to 1.12 79 4 13 0.90 0.46 to 1.74
Spirits
0 6,913 38 1,113 1 Reference 754 37 125 1 Reference
1-2 9,151 50 1,417 0.91 0.83 to 1.00 1,018 51 178 0.89 0.66 to 1.20
3-6 1,100 6 170 0.90 0.76 to 1.06 125 6 25 0.72 0.41 to 1.25
 7 963 5 138 0.82 0.68 to 0.99 117 6 21 1.08 0.60 to 1.96
NOTE. HR adjusted for age at diagnosis, stage of disease at diagnosis, state of residence at diagnosis, study phase, family history of breast cancer, age at first birth,
menopausal status, hormone therapy use, body mass index, smoking status, education, and mammography.
Abbreviation: HR, hazard ratio.
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Table A2. Characteristics at Breast Cancer Diagnosis and at the Follow-Up Interview According to Postdiagnostic Alcohol Consumption
Characteristic
Postdiagnostic Alcohol Consumption (drinks/wk) (N  4,881)
0 (n  1,140)  2 (n  2,232) 3-6 (n  790) 7-9 (n  305)
 10
(n  414)
No. % No. % No. % No. % No. %







MA 1 1 4
NH
WI 1,
First-degree family history of breast cancer
No ,7
Yes
Unknown 18 2 1 4 1








Less than high school diploma 9 3 1
High school diploma 4 3 1 3
Some college 2 1
College degree
Unknown 2 1 0
Mammography




Localized 1,502 5 2





-59 2 2 10 26
-69
 70 9 3







Unknown 1 3 1
Weight change since diagnosis, kg




 10 154 14 309 14 97 12 26 9 42 10
Unknown 48 4 84 4 25 3 11 4 11 3
Alcohol consumption as reported on follow-up questionnaire.
†Premenopausal women are not included.
‡Current as of year before follow-up interview.
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